119th Congress•House
HR. 1843
CommitteeTo amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Latest action
2025-03-05
Referred to the House Committee on Energy and Commerce.
Key actions
- Introduced in House
- Referred to the House Committee on Energy and Commerce.
- Introduced in House
Bill text versions
Related bills
- HR. 7148 (119) · Related billBecame Public Law No: 119-75.
- S. 1302 (119) · Related billRead twice and referred to the Committee on Health, Education, Labor, and Pensions.
- S. 1302 (119) · Related billRead twice and referred to the Committee on Health, Education, Labor, and Pensions.
- S. 891 (119) · Related billRead twice and referred to the Committee on Finance.
- S. 891 (119) · Related billRead twice and referred to the Committee on Finance.
- HR. 1768 (119) · Related billReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Budget, the Judiciary, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- HR. 1768 (119) · Related billReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Budget, the Judiciary, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.